研究結果與臨床意義 結果顯示，舒心救心丸組中有60.9%的患者在4週內達到SAQ總分增加20分以上，相比安慰劑組僅有39.1%的患者達到同樣標準（OR = 2.43，95% CI = 1.32至4.47，P = 0.004）。這意味著舒心救心丸可以顯著提高心絞痛的緩解效果，尤其是在那些無法耐受長效硝酸鹽類副作用的患者中。此外，無飲酒史的患者對舒心救心丸的反應較好，顯示飲酒可能會降低治療效果。
文獻引用 Hu, Y., Wang, Y., & Wang, S. et al. (2024). Efficacy and Safety of Suxiao Jiuxin Pills in the Treatment of Chronic Coronary Syndrome with Intolerance to Adverse Effects of Long-acting Nitrates: A Multicenter, Randomized, Double-blind, Placebo-controlled Study. BMC Complementary Medicine and Therapies, 24, 356. https://doi.org/10.1186/s12906-024-04661-5
Efficacy and Safety of Suxiao Jiuxin Pills in the Treatment of Chronic Coronary Syndrome with Intolerance to Adverse Effects of Long-acting Nitrates: A Multicenter, Randomized, Double-blind, Placebo-controlled Study - BMC Complementary Medicine and Therapies
Background This study aims to investigate the short-term effects and safety of adjunct Suxiao Jiuxin Pills (SJPs) on conventional therapy in chronic coronary syndrome (CCS) patients who are intolerant
